What Did the Research Discover? Researchers investigated whether COVID-19 infection increases the long-term risk of developing autoimmune and autoinflammatory connective tissue disorders. The study included 6,912,427 participants in South Korea, with 3,145,388 individuals who had COVID-19 and 3,767,039 who did not. The participants were followed for at least 180...
For Immediate Release: December 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA posted four warning letters to companies for introducing unapproved GLP-1s, including semaglutide, tirzepatide and/or retatrutide products into interstate commerce. The letters were sent to:Â The...
What did the research discover? This study tested whether methotrexate, a drug used to treat rheumatoid arthritis, could help reduce knee pain and stiffness in people with knee osteoarthritis (KOA). Researchers conducted a randomized, double-blind, placebo-controlled trial across 15 clinics in the United Kingdom, including 207 participants with moderate to severe...
What did the research discover? This study examined whether short-term side effects after receiving an mRNA COVID-19 vaccine are linked to a stronger immune response. Researchers followed 363 adults in the San Francisco Bay Area who received two doses of either the Pfizer (BNT162b2) or Moderna (mRNA-1273) vaccine and had no prior COVID-19 exposure. They measured...
What did the research discover? The U.S. Food and Drug Administration (FDA) has approved and authorized updated mRNA COVID-19 vaccines from Moderna and Pfizer for the 2023-2024 season. These vaccines have been modified to better protect against currently circulating COVID-19 variants, including Omicron XBB.1.5. The update aims to reduce serious outcomes like...
What did the research discover? This study looked at how inflammation and cholesterol levels affect the risk of future heart disease and death in people who are already taking statins (cholesterol-lowering medications). Researchers analyzed data from 31,245 patients in three large clinical trials (PROMINENT, REDUCE-IT, and STRENGTH) to see whether high-sensitivity...